20 Participants Needed

Fitness Tracker for Prostate Cancer Survivors

Recruiting at 1 trial location
CT
GV
SG
Overseen BySarah Gifford
Age: 18+
Sex: Male
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This clinical trial studies how well the InBody Band 3 fitness tracker works to improve physical activity, body composition, and quality of life in Black prostate cancer survivors. Prostate cancer is the most common cancer in men and Black men are more likely to be diagnosed with prostate cancer in an advanced stage. Body composition is associated with disease progression, treatment response, and survival in cancer patients. Reducing stress and maintaining healthy levels of physical activity and sleep are important for a healthy body and improving outcomes, however, there is currently little evidence available on the physical activity, stress levels and sleep patterns in this population. Wearable health activity trackers and smart watches are tools that can be used to track physical activity, stress, sleep and body composition and have been shown to have a positive impact in many patient populations. The InBody Band 3 may be an effective method to improve physical activity, body composition and quality of life in Black prostate cancer survivors.

Will I have to stop taking my current medications?

The trial does not specify whether you need to stop taking your current medications. However, you cannot be undergoing certain cancer therapies like chemotherapy or radiation during the study, except for specific oral or hormonal treatments.

What data supports the effectiveness of the treatment InBody Band 3 Fitness Tracker for prostate cancer survivors?

Research shows that fitness trackers like the Fitbit are comfortable and easy to use for prostate cancer survivors, and they find value in sharing the data with their healthcare team. Additionally, wearable devices have been shown to improve physical activity and health outcomes in cancer survivors, suggesting potential benefits for prostate cancer survivors using similar devices.12345

Is the InBody Band 3 Fitness Tracker safe for prostate cancer survivors?

Research on similar fitness trackers like Fitbit shows they are generally safe and comfortable for cancer survivors, including those with prostate cancer. Participants found these devices easy to wear, and no significant safety issues were reported.16789

How does the InBody Band 3 Fitness Tracker treatment differ from other treatments for prostate cancer survivors?

The InBody Band 3 Fitness Tracker is unique because it focuses on promoting physical activity through a wearable device, which can be easily integrated into daily life and clinical care. Unlike traditional treatments that may involve medication or surgery, this approach encourages lifestyle changes and provides real-time feedback to help prostate cancer survivors improve their health and quality of life.17101112

Research Team

EF

Emma Fortune Ngufor, PhD

Principal Investigator

Mayo Clinic in Rochester

Eligibility Criteria

This trial is for Black prostate cancer survivors to see if the InBody Band 3 fitness tracker can help improve their physical activity, body composition, and quality of life. Participants should be willing to use the device and share data on their activity levels, stress, sleep patterns, and body composition.

Inclusion Criteria

Own and are willing to use a personal smartphone with regular/reliable access to the internet to sync regularly with a fitness tracker
Self-identify as Black
I have an email I check regularly for surveys.
See 5 more

Exclusion Criteria

Have a self-reported history of a psychiatric disorder(s) or moderate to severe cognitive impairment precluding participation in the study intervention or preventing the ability to provide independent informed consent
I spend most of my day in bed.
Live outside of the United States (U.S)
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants wear the InBody Band 3 fitness tracker continuously and participate in weekly check-in/goal-setting discussions

6 weeks
6 visits (virtual)

Follow-up

Participants are monitored for changes in acceptability and adherence rates

2 weeks

Treatment Details

Interventions

  • InBody Band 3 Fitness Tracker
Trial Overview The study is testing whether using the InBody Band 3 fitness tracker encourages better health habits in Black prostate cancer survivors. It involves discussions with researchers, answering questionnaires, and regular usage of this medical device to monitor various health metrics.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Supportive care (InBody Band 3 fitness tracker)Experimental Treatment3 Interventions
Patients wear the InBody Band 3 fitness tracker continuously and participate in check-in/goal-setting discussions over 20-30 minutes weekly for 6 weeks.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+

Findings from Research

A 3-week study involving 26 men with prostate cancer found that the Fitbit Zip was generally accepted, with participants finding it comfortable and easy to wear.
Participants expressed interest in sharing their fitness tracking data with healthcare providers, indicating potential for integrating such devices into clinical care to support physical activity and health management.
Acceptability of Fitbit for physical activity tracking within clinical care among men with prostate cancer.Rosenberg, D., Kadokura, EA., Bouldin, ED., et al.[2022]
The OncoActive intervention, which provided personalized physical activity feedback to prostate and colorectal cancer survivors, did not show significant long-term differences in physical activity levels compared to a control group at the 12-month follow-up, although self-reported days of physical activity were higher in the OncoActive group.
Participants in the OncoActive group experienced significantly lower fatigue levels compared to the control group at 12 months, suggesting that the intervention may help improve certain health-related outcomes even if physical activity levels did not differ significantly.
Long-term efficacy of a computer-tailored physical activity intervention for prostate and colorectal cancer patients and survivors: A randomized controlled trial.Golsteijn, RHJ., Bolman, C., Peels, DA., et al.[2023]
A scoping review of 16 studies identified key barriers for prostate cancer survivors in making lifestyle changes, including a perceived lack of evidence for dietary guidelines, treatment side effects, and time constraints.
Facilitators for lifestyle changes included support from health professionals and family, viewing diagnosis as a motivation for change, and using lifestyle adjustments as coping strategies to manage side effects and enhance well-being.
Facilitators and barriers to participation in lifestyle modification for men with prostate cancer: A scoping review.Yannitsos, D., Murphy, RA., Pollock, P., et al.[2020]

References

Acceptability of Fitbit for physical activity tracking within clinical care among men with prostate cancer. [2022]
Long-term efficacy of a computer-tailored physical activity intervention for prostate and colorectal cancer patients and survivors: A randomized controlled trial. [2023]
Facilitators and barriers to participation in lifestyle modification for men with prostate cancer: A scoping review. [2020]
Effect and feasibility of wearable physical activity trackers and pedometers for increasing physical activity and improving health outcomes in cancer survivors: A systematic review and meta-analysis. [2022]
A distance-based, randomized controlled trial for reducing sedentary behavior among prostate cancer survivors: a study protocol. [2022]
Increasing physical activity in Cancer Survivors through a Text-messaging Exercise motivation Program (ICanSTEP). [2022]
Use of consumer wearable devices to promote physical activity among breast, prostate, and colorectal cancer survivors: a review of health intervention studies. [2020]
An Evaluation of Participant Perspectives and Wear-Time Compliance for a Wrist-Worn Versus Thigh-Worn Accelerometer in Cancer Survivors. [2023]
Systematic Review of Randomized Controlled Trials of Exercise Interventions Using Digital Activity Trackers in Patients With Cancer. [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
Internet of things-based lifestyle intervention for prostate cancer patients on androgen deprivation therapy: a prospective, multicenter, randomized trial. [2021]
Barriers and applied activity, quality of life and self-efficacy in prostate cancer survivors 1 year after completing radiotherapy. [2023]
Physical exercise habits, lifestyle behaviors, and motivation to change among men with prostate cancer: a cross-sectional study. [2022]